Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Malignant Melanoma

  Free Subscription


29.01.2024

1 Ann Surg Oncol
1 Br J Cancer
2 Br J Dermatol
1 Cancer Lett
1 Clin Cancer Res
3 J Am Acad Dermatol
1 Lancet
1 Melanoma Res
1 Nat Med
1 Oncogene
1 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Surg Oncol

  1. ROSHAN A, Shah B, Anderson KD, Murphy S, et al
    ASO Visual Abstract: Robot-Assisted Pelvic Dissection for Enlarged Lymph Nodes in Melanoma Improves Recovery with Equivalent Oncological Outcomes to Open Pelvic Dissection.
    Ann Surg Oncol. 2024 Jan 22. doi: 10.1245/s10434-024-14920.
    PubMed        


    Br J Cancer

  2. ZAKKAK N, Barclay ME, Swann R, McPhail S, et al
    The presenting symptom signatures of incident cancer: evidence from the English 2018 National Cancer Diagnosis Audit.
    Br J Cancer. 2024;130:297-307.
    PubMed         Abstract available


    Br J Dermatol


  3. Risk factors for developing a new primary melanoma in people with a melanoma.
    Br J Dermatol. 2024;190:e15.
    PubMed        


  4. Genes associated with nodular melanoma.
    Br J Dermatol. 2024;190:e18.
    PubMed        


    Cancer Lett

  5. LIU C, Cheng X, Han K, Hong L, et al
    A novel molecular subtyping based on multi-omics analysis for prognosis predicting in colorectal melanoma: A 16-year prospective multicentric study.
    Cancer Lett. 2024 Jan 19:216663. doi: 10.1016/j.canlet.2024.216663.
    PubMed         Abstract available


    Clin Cancer Res

  6. ANDERSON TM, Chang BH, Huang AC, Xu X, et al
    FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma.
    Clin Cancer Res. 2024 Jan 24:OF1-OF10. doi: 10.1158/1078-0432.CCR-23-2390.
    PubMed         Abstract available


    J Am Acad Dermatol

  7. CHOI ME, Jung JM, Kim DH, Won CH, et al
    Baseline Serum Neutrophil-to-Lymphocyte Ratio in Acral Melanoma Compared to Non-Acral Melanoma and its Prognostic Significance.
    J Am Acad Dermatol. 2024 Jan 23:S0190-9622(24)00103.
    PubMed         Abstract available

  8. TATE JA, Matsumoto A, Greif C, Lim J, et al
    Excision Margins for Melanoma in Situ on the Head and Neck - A Single-Center 10-year Retrospective Review of Treatment with Mohs Micrographic Surgery.
    J Am Acad Dermatol. 2024 Jan 20:S0190-9622(24)00102.
    PubMed         Abstract available

  9. SHIFAI N, van Doorn R, Malvehy J, Sangers T, et al
    Can ChatGPT Vision Diagnose Melanoma? An Exploratory Diagnostic Accuracy Study.
    J Am Acad Dermatol. 2024 Jan 18:S0190-9622(24)00076.
    PubMed        


    Lancet

  10. WEBER JS, Carlino MS, Khattak A, Meniawy T, et al
    Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study.
    Lancet. 2024 Jan 18:S0140-6736(23)02268-7. doi: 10.1016/S0140-6736(23)02268.
    PubMed         Abstract available


    Melanoma Res

  11. DAVIDSON TM, Hieken TJ, Glasgow AE, Habermann EB, et al
    Pregnancy-associated melanoma: characteristics and outcomes from 2002 to 2020.
    Melanoma Res. 2024 Jan 23. doi: 10.1097/CMR.0000000000000953.
    PubMed         Abstract available


    Nat Med

  12. O'LEARY K
    Personalized mRNA vaccine boosts melanoma immunotherapy.
    Nat Med. 2024 Jan 25. doi: 10.1038/d41591-024-00006.
    PubMed        


    Oncogene

  13. CANNON AC, Budagyan K, Uribe-Alvarez C, Kurimchak AM, et al
    Unique vulnerability of RAC1-mutant melanoma to combined inhibition of CDK9 and immune checkpoints.
    Oncogene. 2024 Jan 19. doi: 10.1038/s41388-024-02947.
    PubMed         Abstract available


    PLoS One

  14. LIU Y, Wang S, Wei S, Qiu X, et al
    The promotive role of lncRNA MIR205HG in proliferation, invasion, and migration of melanoma cells via the JMJD2C/ALKBH5 axis.
    PLoS One. 2024;19:e0290986.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  15. BANUELOS A, Zhang A, Berouti H, Baez M, et al
    CXCR2 inhibition in G-MDSCs enhances CD47 blockade for melanoma tumor cell clearance.
    Proc Natl Acad Sci U S A. 2024;121:e2318534121.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.